• Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts

    المصدر: Buzz FX / 14 نوفمبر 2024 02:11:19   America/Chicago


    Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Shares of Crinetics Pharmaceuticals, Inc.
    Read more...
شارك على،